Multicenter Cohort Study of Ceftaroline Versus Daptomycin for Treatment of Methicillin-Resistant Staphylococcus aureus Bloodstream Infection.
Evan J ZasowskiTrang D TrinhKimberly C ClaeysAbdalhamid M LagnfSahil BhatiaKenneth P KlinkerMichael P VeveSandy J EstradaScott T JohnsAdam J SawyerVanthida HuangBrandi LaFranceDonald P LevineKeith S KayeSusan L DavisMichael J RybakPublished in: Open forum infectious diseases (2021)
No difference in treatment failure or mortality was observed between MRSA BSI treated with ceftaroline or daptomycin. These data support future study of ceftaroline as a primary MRSA BSI treatment and current use of ceftaroline when an alternative to vancomycin and daptomycin is required.